HOMEABOUT MEDAFINANCIAL INFORMATIONNEWSPRODUCTSCONTACT US

NEWS

  

Year 2009

FDA accepts NDA filing for Retigabine2009-12-30 14:07 - Pressrelease - pdf
Meda expands Axorid collaboration2009-12-30 10:00 - Pressrelease - pdf
Meda strengthens the financial headroom2009-12-07 11:10 - Pressrelease - pdf
Meda AB (publ) - Interim report, January–September 20092009-11-03 08:00 - Quarterly report - pdf
Retigabine filings completed in the US and Europe2009-11-02 14:13 - Pressrelease - pdf
Nomination committee appointed2009-10-26 15:00 - Pressrelease - pdf
Onsolis filed in Canada2009-10-02 13:00 - Pressrelease - pdf
Expanded rights for azelastine and fluticasone combination2009-09-07 16:12 - Pressrelease - pdf
FDA approval of the first once-daily nasal antihistamine2009-09-02 13:15 - Pressrelease - pdf
Meda AB (publ) – Interim report, January–June 20092009-08-18 08:00 - Half Year financial report - pdf
Onsolis receives FDA approval2009-07-17 08:00 - Pressrelease - pdf
FDA approval for Onsolis anticipated during summer 20092009-06-15 08:30 - Pressrelease - pdf
Positive study supporting a potential once-daily nasal antihistamine2009-05-28 11:15 - Pressrelease - pdf
Meda AB (publ) AGM bulletin2009-05-05 20:30 - Minutes of annual general meeting - pdf
Meda AB (publ) – Interim report January–March 20092009-05-05 08:00 - Quarterly report - pdf
Meda AB (publ): Notification to shareholders of the annual general meeting2009-04-07 08:00 - Notice to convene annual general meeting - pdf
Edluar receives FDA approval2009-03-16 08:30 - Pressrelease - pdf
CEO acquires call options from Stena Sessan2009-03-10 08:00 - Pressrelease - pdf
Meda AB (publ) – 2008 year-end report2009-02-19 08:00 - Annual Financial Statement - pdf
Meda acquires world-wide rights to Onsolis2009-01-05 11:55 - Pressrelease - pdf